SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

ThermoGenesis Holdings, Inc. – ‘8-K’ for 6/4/20

On:  Tuesday, 6/9/20, at 4:45pm ET   ·   For:  6/4/20   ·   Accession #:  1437749-20-12750   ·   File #:  333-82900

Previous ‘8-K’:  ‘8-K’ on 5/20/20 for 5/19/20   ·   Next:  ‘8-K’ on 7/14/20 for 7/10/20   ·   Latest:  ‘8-K’ on 3/20/24 for 3/15/24   ·   14 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/09/20  ThermoGenesis Holdings, Inc.      8-K:5,9     6/04/20    4:174K                                   RDG Filings/FA

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     50K 
 2: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML     21K 
 3: EX-10.1     Material Contract                                   HTML     10K 
 4: EX-10.2     Material Contract                                   HTML     34K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:  <>  <> 

 


 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 4, 2020

 

THERMOGENESIS HOLDINGS, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

 

 

   

Delaware

 

333-82900

 

94-3018487

 

 

 

 

 

(State or Other Jurisdiction

 

(Commission

 

(IRS Employer

of Incorporation)

 

File Number)

 

Identification No.)

 

 

 

   

2711 Citrus Road, Rancho Cordova, California

 

95742

 

 

 

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code (949) 753-0624

 

N/A
(Former Name or Former Address, if Changed Since Last Report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading symbol(s)

Name of each exchange on which registered

Common Stock, $.001 par value

THMO

Nasdaq Capital Market

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

      ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

      ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

      ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

      ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

          Emerging growth company      ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 



 

 

 

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Non-Employee Director Compensation Plan

 

On June 4, 2020, the Board of Directors of ThermoGenesis Holdings, Inc. (the “Company”) approved the following annual cash compensation plan for non-employee directors effective July 1, 2020:

 

 

Committee Chairman

Non-Chairman Member

Board of Directors

N/A

$35,000

Audit Committee

$15,000

$7,500

Compensation Committee

$10,000

$5,000

Governance and Nominating Committee

$7,000

$3,500

Fees are paid in quarterly installments.

 

In addition, the Board of Directors approved a one-time stock option grant pursuant to the Company’s 2016 Equity Incentive Plan (the “2016 Plan”) to non-employee directors for 10,000 non-qualified stock options each at an exercise price of $5.94, which represents the closing price of the Company’s common stock on June 4, 2020. The options will vest immediately with an expiration date of June 4, 2030. The options will otherwise be subject to the terms and conditions of the 2016 Plan and the applicable award agreement, including provisions relating to termination of the option upon cessation of director service.

 

Approval of Amendment to 2016 Equity Incentive Plan

 

On June 4, 2020, the Board of Directors of the Company approved and adopted an amendment (the “Plan Amendment”) to the 2016 Plan to increase the aggregate number of shares that may be issued under the 2016 Plan from 392,500 shares to 1,273,000 shares. The Plan Amendment will be null and void if not approved by the Company’s stockholders prior to June 3, 2021. The foregoing description of the Plan Amendment is qualified in its entirety by reference to the actual text of the Plan Amendment attached hereto as Exhibit 10.1 and which is incorporated herein by reference.

 

Management Stock Option Grant

 

On June 4, 2020, the Company’s Board of Directors granted stock options to purchase an aggregate of 571,500 shares of Company common stock to certain employees and executives of the Company. The options were granted pursuant to the 2016 Plan, as amended by the Plan Amendment. The options were granted at an exercise price of $5.94 per share, which represents the closing price of the Company’s common stock on June 4, 2020. The options vest in four equal installments on each of the first four anniversaries of the grant date. The option exercise price is subject to adjustment as set forth in the 2016 Plan and the applicable award agreement, and the options will expire on the 10th anniversary of the grant date and be otherwise subject to the terms and conditions (including early termination provisions) of the 2016 Plan and the applicable award agreement.

 

Included in the option grants were grants to the Company’s executive officers in the following amounts:

 

Name and Title

Number of Options Granted

Xiaochun “Chris” Xu, Chief Executive Officer

240,000

Jeff Cauble, Chief Financial Officer

40,000

 

No portion of the options may be exercised until the Company’s stockholders have voted to approve the Plan Amendment. The options shall be deemed cancelled and void without any further action by the Company if the Company’s stockholders have not approved the 2016 Plan Amendment on or before June 3, 2021.

 

 

 

Item 5.03.

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

 

On June 4, 2020, the Company held its 2020 annual meeting of stockholders (the “Annual Meeting”), at which the Company’s stockholders voted to, among other things, approve the adoption of an Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate”). The Amended and Restated Certificate amends and restates the Company’s Sixth Amended and Restated Certificate of Incorporation, as amended (the “Prior Certificate”), by:

 

 

authorizing 100,000,000 shares of a new class of nonvoting common stock, par value $0.001 per share, to be designated as “Class B Common Stock”;

 

 

fixing and establishing the relative rights, powers and limitations of the Company’s proposed Class B Common Stock, including in comparison to the rights, powers and limitations of the Company’s Common Stock, and

 

 

restating and integrating the provisions of the Prior Certificate (including the multiple amendments included therein) into a single document and deleting sections of the Prior Certificate that are no longer applicable.

 

On June 5, 2020, the Company filed the Amended and Restated Certificate with the Secretary of State of Delaware.

 

The foregoing summary does not purport to be complete and is qualified in its entirety by the full text of the Amended and Restated Certificate, which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Item 5.07.

Submission of Matters to a Vote of Security Holders.

 

At the Company’s Annual Meeting on June 4, 2020, the following proposals were approved according to the following final voting results:

 

 

1.

To approve the election of the following individuals as directors to the Board of Directors:

 

Xiaochun Xu        

For

    3,107,868  

Withhold

    34,450  

Broker Non-Votes

    1,823,247  

Uncast

    0  

 

Debra Donaghy

       

For

    3,108,043  

Withhold

    34,275  

Broker Non-Votes

    1,823,247  

Uncast

    0  

 

Russell Medford

       

For

    3,107,439  

Withhold

    34,879  

Broker Non-Votes

    1,823,247  

Uncast

    0  

 

Joseph Thomis

       

For

    3,105,402  

Withhold

    36,916  

Broker Non-Votes

    1,823,247  

Uncast

    0  

 

 

 

Mark Westgate

       

For

    3,105,329  

Withhold

    36,989  

Broker Non-Votes

    1,823,247  

Uncast

    0  

 

 

 

2.

To approve the potential issuance of in excess of 19.99% of the Company’s outstanding common stock upon the conversion of an outstanding convertible note:

 

For

    3,021,568  

Against

    94,516  

Abstain

    26,234  

Broker Non-Votes

    1,823,247  

Uncast

    0  

 

 

 

3.

To approve the adoption of an Amended and Restated Certificate of Incorporation:

 

For

    2,959,161  

Against

    156,147  

Abstain

    27,010  

Broker Non-Votes

    1,823,247  

Uncast

    0  

 

 

 

4.

To ratify the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020:

 

For

    4,868,252  

Against

    55,406  

Abstain

    41,907  

Broker Non-Votes

    0  

Uncast

    0  

 

 

 

5.

To approve, on an advisory basis, the compensation of the Company’s named executive officers:

 

For

    3,051,177  

Against

    70,820  

Abstain

    20,321  

Broker Non-Votes

    1,823,247  

Uncast

    0  

 

The stockholders did not vote on any other matters at the Annual Meeting.

 

Item 9.01.

Financial Statements and Exhibits.

 

(d)

Exhibits.

 

  Exhibit No.   Description of Exhibit
  3.1   Amended and Restated Certificate of Incorporation of ThermoGenesis Holdings, Inc.
  10.1   Fourth Amendment to the ThermoGenesis Holdings, Inc. 2016 Equity Incentive Plan, effective June 4, 2020.
  10.2    Form of Stock Option Agreement.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

THERMOGENESIS HOLDINGS, INC.

   

(Registrant)

Dated: June 9, 2020

 

/s/ Xiaochun Xu

   

Xiaochun (Chris) Xu, Chief Executive Officer

 

 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
6/4/30
6/3/21
12/31/20
7/1/20
Filed on:6/9/20
6/5/20
For Period end:6/4/204,  DEF 14A,  PRE 14A
 List all Filings 


14 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/16/24  ThermoGenesis Holdings, Inc.      10-K       12/31/23   85:8.1M                                   RDG Filings/FA
 4/13/23  ThermoGenesis Holdings, Inc.      S-3/A                  1:74K                                    RDG Filings/FA
 4/04/23  ThermoGenesis Holdings, Inc.      S-3                    4:241K                                   RDG Filings/FA
 3/30/23  ThermoGenesis Holdings, Inc.      10-K       12/31/22   88:8.1M                                   RDG Filings/FA
11/10/22  ThermoGenesis Holdings, Inc.      10-Q        9/30/22   54:4.6M                                   RDG Filings/FA
10/17/22  ThermoGenesis Holdings, Inc.      S-1/A      10/14/22    5:744K                                   RDG Filings/FA
 8/11/22  ThermoGenesis Holdings, Inc.      10-Q        6/30/22   54:4.5M                                   RDG Filings/FA
 5/27/22  ThermoGenesis Holdings, Inc.      S-1/A       5/26/22    3:397K                                   RDG Filings/FA
 5/20/22  ThermoGenesis Holdings, Inc.      10-Q        3/31/22   50:3.4M                                   RDG Filings/FA
 4/29/22  ThermoGenesis Holdings, Inc.      S-1/A                  7:866K                                   RDG Filings/FA
 4/12/22  ThermoGenesis Holdings, Inc.      S-1         4/11/22    3:381K                                   RDG Filings/FA
 3/28/22  ThermoGenesis Holdings, Inc.      10-K       12/31/21   89:7.6M                                   RDG Filings/FA
 3/17/21  ThermoGenesis Holdings, Inc.      10-K       12/31/20   81:7M                                     RDG Filings/FA
 8/14/20  ThermoGenesis Holdings, Inc.      10-Q        6/30/20   54:8.9M                                   RDG Filings/FA
Top
Filing Submission 0001437749-20-012750   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 20, 2:31:14.2am ET